Crossref logo
Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness
Lee,Yong-ho et al.
Journal of Korean Medical Science(2017),32(1):60
http://dx.doi.org/10.3346/jkms.2017.32.1.60